Got a tip for us?
Let us know
Become a MacRumors Supporter for $50/year with no ads, ability to filter front page stories, and private forums.
Phil Schiller Named to DNA Sequencing Company Illumina's Board of Directors
- Thread starter MacRumors
- Start date
- Sort by reaction score
But he CAN innovate his ass because he can change his ass gene.Insert token, "Can't innovate any more my..." comment.
I present you... the iPhone "5SE"! With rounded corners, with camera bump, and iPhone 6-like antenna lines:
And the Chinese fake take on it:
They were right, it had 4"
[doublepost=1469712581][/doublepost]
I can't bet that money, but I'm willing to bet, where can we actually bet?
WOw. Is that copper like new colour?
How so? its reeking of click bait move to generate press.
just not seeing him create tidal waves has in this area...people kind of sort need something beside lets release in rose gold to do something different. Or make a new watch band to join the other ones (had to go there lol).
This area is based on more than. First you have ye old bp per dollar as the guide. Illumina versus the other biotech firms....who is giving you the most base pair performance for the least amount of money with acceptable accuracy rates and results you can build analysis pipelines from cost effectively.\
Something apple not is really good at. doing more for less. I will make the joke with the electronics anorexia phase they are in he is quite the opposite, sell less for more and see who bites. But...its smaller. yes I get that. They are removing stuff, using less materials...and charging more? This marketing angle I will say yes,...yes he is damn good lol.
He is also entering a realm where some have set in stone budget limits. Its a realm that may be a bit different for him. Its not like apple devices where I can say I can sell my mini 4, make up the difference and buy the IPP. This would be how I could buy a new IPP if desired.
If illumina is not reaching some markets a very likely reason is they went to option B because on day one of fiscal year that research division got all the money they are going to get. If illumina not in the budget that day due to higher costs vice other options, they probably won't be buying into it mid cycle either.